Hepatitis A Vaccine Industry Research Report 2024
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, the global Hepatitis A Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The report will help the Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hepatitis A Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, the global Hepatitis A Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hepatitis A Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis A Vaccine.
The report will help the Hepatitis A Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Hepatitis A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis A Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCA
- ChangSheng
- Convac
- Inactivated Vaccine
- Live Attenuated Vaccine
- Government Institution
- Private Sector
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Hepatitis A Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Hepatitis A Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Hepatitis A Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Hepatitis A Vaccine Sales (2019-2030)
2.2.3 Global Hepatitis A Vaccine Market Average Price (2019-2030)
2.3 Hepatitis A Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Inactivated Vaccine
2.3.3 Live Attenuated Vaccine
2.4 Hepatitis A Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Government Institution
2.4.3 Private Sector
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Hepatitis A Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Hepatitis A Vaccine Sales (K Unit) of Manufacturers (2019-2024)
3.3 Global Hepatitis A Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Hepatitis A Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Hepatitis A Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Hepatitis A Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Hepatitis A Vaccine, Product Type & Application
3.8 Global Manufacturers of Hepatitis A Vaccine, Date of Enter into This Industry
3.9 Global Hepatitis A Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK Hepatitis A Vaccine Product Portfolio
4.1.5 GSK Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Merck Hepatitis A Vaccine Product Portfolio
4.2.5 Merck Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Sinovac
4.4.1 Sinovac Company Information
4.4.2 Sinovac Business Overview
4.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
4.4.5 Sinovac Recent Developments
4.5 Zhejiang Pukang
4.5.1 Zhejiang Pukang Company Information
4.5.2 Zhejiang Pukang Business Overview
4.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
4.5.5 Zhejiang Pukang Recent Developments
4.6 Changchun Institute of Biological
4.6.1 Changchun Institute of Biological Company Information
4.6.2 Changchun Institute of Biological Business Overview
4.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
4.6.5 Changchun Institute of Biological Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 IMBCA
4.8.1 IMBCA Company Information
4.8.2 IMBCA Business Overview
4.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
4.8.5 IMBCA Recent Developments
4.9 ChangSheng
4.9.1 ChangSheng Company Information
4.9.2 ChangSheng Business Overview
4.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
4.9.5 ChangSheng Recent Developments
4.10 Convac
4.10.1 Convac Company Information
4.10.2 Convac Business Overview
4.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Convac Hepatitis A Vaccine Product Portfolio
4.10.5 Convac Recent Developments
5 GLOBAL HEPATITIS A VACCINE MARKET SCENARIO BY REGION
5.1 Global Hepatitis A Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Hepatitis A Vaccine Sales by Region: 2019-2030
5.2.1 Global Hepatitis A Vaccine Sales by Region: 2019-2024
5.2.2 Global Hepatitis A Vaccine Sales by Region: 2025-2030
5.3 Global Hepatitis A Vaccine Revenue by Region: 2019-2030
5.3.1 Global Hepatitis A Vaccine Revenue by Region: 2019-2024
5.3.2 Global Hepatitis A Vaccine Revenue by Region: 2025-2030
5.4 North America Hepatitis A Vaccine Market Facts & Figures by Country
5.4.1 North America Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Hepatitis A Vaccine Sales by Country (2019-2030)
5.4.3 North America Hepatitis A Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Hepatitis A Vaccine Market Facts & Figures by Country
5.5.1 Europe Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Hepatitis A Vaccine Sales by Country (2019-2030)
5.5.3 Europe Hepatitis A Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Hepatitis A Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Hepatitis A Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
5.7.1 Latin America Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Hepatitis A Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Hepatitis A Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Hepatitis A Vaccine Sales by Type (2019-2030)
6.1.1 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (K Unit)
6.1.2 Global Hepatitis A Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Hepatitis A Vaccine Revenue by Type (2019-2030)
6.2.1 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Hepatitis A Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Hepatitis A Vaccine Sales by Application (2019-2030)
7.1.1 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (K Unit)
7.1.2 Global Hepatitis A Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Hepatitis A Vaccine Revenue by Application (2019-2030)
7.2.1 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Hepatitis A Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Hepatitis A Vaccine Value Chain Analysis
8.1.1 Hepatitis A Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Hepatitis A Vaccine Production Mode & Process
8.2 Hepatitis A Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Hepatitis A Vaccine Distributors
8.2.3 Hepatitis A Vaccine Customers
9 GLOBAL HEPATITIS A VACCINE ANALYZING MARKET DYNAMICS
9.1 Hepatitis A Vaccine Industry Trends
9.2 Hepatitis A Vaccine Industry Drivers
9.3 Hepatitis A Vaccine Industry Opportunities and Challenges
9.4 Hepatitis A Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Hepatitis A Vaccine Market Size (2019-2030) & (US$ Million)
2.2.2 Global Hepatitis A Vaccine Sales (2019-2030)
2.2.3 Global Hepatitis A Vaccine Market Average Price (2019-2030)
2.3 Hepatitis A Vaccine by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Inactivated Vaccine
2.3.3 Live Attenuated Vaccine
2.4 Hepatitis A Vaccine by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Government Institution
2.4.3 Private Sector
2.4.4 Other
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Hepatitis A Vaccine Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Hepatitis A Vaccine Sales (K Unit) of Manufacturers (2019-2024)
3.3 Global Hepatitis A Vaccine Revenue of Manufacturers (2019-2024)
3.4 Global Hepatitis A Vaccine Average Price by Manufacturers (2019-2024)
3.5 Global Hepatitis A Vaccine Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Hepatitis A Vaccine, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Hepatitis A Vaccine, Product Type & Application
3.8 Global Manufacturers of Hepatitis A Vaccine, Date of Enter into This Industry
3.9 Global Hepatitis A Vaccine Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GSK
4.1.1 GSK Company Information
4.1.2 GSK Business Overview
4.1.3 GSK Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GSK Hepatitis A Vaccine Product Portfolio
4.1.5 GSK Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.4 Merck Hepatitis A Vaccine Product Portfolio
4.2.5 Merck Recent Developments
4.3 Sanofi
4.3.1 Sanofi Company Information
4.3.2 Sanofi Business Overview
4.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
4.3.5 Sanofi Recent Developments
4.4 Sinovac
4.4.1 Sinovac Company Information
4.4.2 Sinovac Business Overview
4.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
4.4.5 Sinovac Recent Developments
4.5 Zhejiang Pukang
4.5.1 Zhejiang Pukang Company Information
4.5.2 Zhejiang Pukang Business Overview
4.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
4.5.5 Zhejiang Pukang Recent Developments
4.6 Changchun Institute of Biological
4.6.1 Changchun Institute of Biological Company Information
4.6.2 Changchun Institute of Biological Business Overview
4.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
4.6.5 Changchun Institute of Biological Recent Developments
4.7 KM Biologics
4.7.1 KM Biologics Company Information
4.7.2 KM Biologics Business Overview
4.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
4.7.5 KM Biologics Recent Developments
4.8 IMBCA
4.8.1 IMBCA Company Information
4.8.2 IMBCA Business Overview
4.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
4.8.5 IMBCA Recent Developments
4.9 ChangSheng
4.9.1 ChangSheng Company Information
4.9.2 ChangSheng Business Overview
4.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
4.9.5 ChangSheng Recent Developments
4.10 Convac
4.10.1 Convac Company Information
4.10.2 Convac Business Overview
4.10.3 Convac Hepatitis A Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Convac Hepatitis A Vaccine Product Portfolio
4.10.5 Convac Recent Developments
5 GLOBAL HEPATITIS A VACCINE MARKET SCENARIO BY REGION
5.1 Global Hepatitis A Vaccine Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Hepatitis A Vaccine Sales by Region: 2019-2030
5.2.1 Global Hepatitis A Vaccine Sales by Region: 2019-2024
5.2.2 Global Hepatitis A Vaccine Sales by Region: 2025-2030
5.3 Global Hepatitis A Vaccine Revenue by Region: 2019-2030
5.3.1 Global Hepatitis A Vaccine Revenue by Region: 2019-2024
5.3.2 Global Hepatitis A Vaccine Revenue by Region: 2025-2030
5.4 North America Hepatitis A Vaccine Market Facts & Figures by Country
5.4.1 North America Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Hepatitis A Vaccine Sales by Country (2019-2030)
5.4.3 North America Hepatitis A Vaccine Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Hepatitis A Vaccine Market Facts & Figures by Country
5.5.1 Europe Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Hepatitis A Vaccine Sales by Country (2019-2030)
5.5.3 Europe Hepatitis A Vaccine Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Hepatitis A Vaccine Market Facts & Figures by Country
5.6.1 Asia Pacific Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Hepatitis A Vaccine Sales by Country (2019-2030)
5.6.3 Asia Pacific Hepatitis A Vaccine Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Hepatitis A Vaccine Market Facts & Figures by Country
5.7.1 Latin America Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Hepatitis A Vaccine Sales by Country (2019-2030)
5.7.3 Latin America Hepatitis A Vaccine Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Hepatitis A Vaccine Market Facts & Figures by Country
5.8.1 Middle East and Africa Hepatitis A Vaccine Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Hepatitis A Vaccine Sales by Country (2019-2030)
5.8.3 Middle East and Africa Hepatitis A Vaccine Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Hepatitis A Vaccine Sales by Type (2019-2030)
6.1.1 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (K Unit)
6.1.2 Global Hepatitis A Vaccine Sales Market Share by Type (2019-2030)
6.2 Global Hepatitis A Vaccine Revenue by Type (2019-2030)
6.2.1 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Hepatitis A Vaccine Revenue Market Share by Type (2019-2030)
6.3 Global Hepatitis A Vaccine Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Hepatitis A Vaccine Sales by Application (2019-2030)
7.1.1 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (K Unit)
7.1.2 Global Hepatitis A Vaccine Sales Market Share by Application (2019-2030)
7.2 Global Hepatitis A Vaccine Revenue by Application (2019-2030)
7.2.1 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
7.3 Global Hepatitis A Vaccine Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Hepatitis A Vaccine Value Chain Analysis
8.1.1 Hepatitis A Vaccine Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Hepatitis A Vaccine Production Mode & Process
8.2 Hepatitis A Vaccine Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Hepatitis A Vaccine Distributors
8.2.3 Hepatitis A Vaccine Customers
9 GLOBAL HEPATITIS A VACCINE ANALYZING MARKET DYNAMICS
9.1 Hepatitis A Vaccine Industry Trends
9.2 Hepatitis A Vaccine Industry Drivers
9.3 Hepatitis A Vaccine Industry Opportunities and Challenges
9.4 Hepatitis A Vaccine Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
